Skip to content
SANW

S&W Seed Co

S&W Seed Co Q2 FY2024 earnings call

February 14, 2024 · fiscal period ended 2023-12

EPS · actual vs est

$-2.47 / $-0.11Miss -2145.5%

Revenue · actual vs est

$10.9M / $14.0MMiss -22.4%
Ask about this call

Summary

Generated 2024-02-14

Management highlights

  • Vanessa Baughman's permanent CFO role was highlighted, having served as Interim CFO since May 2023.
  • Operational initiatives include improved lifecycle management, rationalization of low-margin forage product lines and seed treatments, suspension of stevia development, and cost reduction. Gross margins were above 30% for the second consecutive quarter, and operating expenses were reduced by over $1 million.
  • Double Team Grain Sorghum sales in Q2 2024 were up 233% to $4 million, with strong farmer satisfaction, and it's estimated to account for 6% of US grain sorghum acres planted in spring 2023, expected to grow to over 10% in 2024.
  • Plans to introduce Double Team forage sorghum solution and prussic acid-free trait for sorghum, with initial Double Team forage sorghum sales expected in fiscal 2024 and a pilot launch of prussic acid-free trait this year.
  • Agreement with Shell to develop Camelina as a feedstock for biofuels, green diesel, and SAF jet fuel production, with $6 million payment received in February 2024.
  • Monitoring geopolitical conflicts in MENA region impacting international alfalfa operations and Australia pasture supply shortages, with cost-cutting and production optimization initiatives underway.
View in transcript ↓

Segment performance

Total revenue for Q2 2024 was $10.9 million, down from $12.9 million in Q2 2023. Sorghum sales were $5.5 million vs $2 million last year, with Double Team sorghum at $4 million vs $1.2 million in Q2 last year, a 233% increase. International forage sales were $3.6 million vs $8.6 million, down $5 million. US forage sales were $1.4 million vs $2.3 million, down $900,000. GAAP gross margins for Q2 2024 were 30.3% vs 21.3% in Q2 2023, the second consecutive quarter above 30%.

View in transcript ↓

Guidance

  • Fiscal 2024 revenue expected on the lower end of the previously communicated range of $76 million to $82 million.
  • Sorghum-related revenue expected to be between $22 million and $23 million, with Double Team expected to be $11.5 million to $14 million.
  • International revenue expected on the low end of $45 million to $50 million.
  • US forage operations revenue expected at about $9 million vs $10.8 million last year.
  • Full year gross margins expected between 24% and 26%.
  • Adjusted EBITDA guidance: negative $7.5 million to negative $4 million for fiscal 2024.
View in transcript ↓

Risks

  • Geopolitical conflicts in the MENA region causing disruptions to normal farming operations and seed distribution channels, impacting international alfalfa operations.
  • Shortage in supply within the Australia pasture business, limiting ability to meet demand.
View in transcript ↓

Q&A highlights

Q: Please provide an update on the status of the strategic review for Australian operations and its relation to macro dynamics in Australia.

A: On the strategic review, several initiatives were deemed not beneficial for shareholders, and eight significant cost-streamlining initiatives are being implemented by the local team, with financial benefits mostly in the 2025 fiscal year.

Q: Regarding Double Team sorghum, was the second quarter revenue of this magnitude anticipated, and any uncertainty around inventory for hitting the high-end of the full-year target?

A: The 233% increase in Double Team sorghum revenue in Q2 was consistent with forecasts. Inventory is solid, with good supply of Double Team sorghum products and confidence in meeting the high-end revenue target for Double Team.

Q: Regarding Vision Bio, is it still expected that it won't consume S&W cash in the near future?

A: Yes, it's still consistent with the original deal, with Shell's funding and Vision Bio's milestones, and it's anticipated to be cash neutral for the near term.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-2.47$-0.11-2145.5%$-2.47
Revenue$10.9M$14.0M-22.4%$12.9M

Transcript

February 14, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.